Medtronic
Johnson & Johnson
C.R. Bard
GE Healthcare
Siemens Healthcare
Philips Healthcare
Nihon Kohden
Compumedics
Toshiba
Medtronic (Covidien)
Natus Medical Incorporated
Advanced Brain Monitoring
Integra LifeSciences
CAS Medical Systems
地理的地域による市場細分化では、レポートは次の地域を分析しました-
北米（米国、カナダ、メキシコ）
ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
アジア太平洋（中国、日本、韓国、インド、東南アジア）
南アメリカ（ブラジル、アルゼンチン、コロンビアなど）
中東およびアフリカ（サウジアラビア、アラブ首長国連邦、エジプト、ナイジェリア、南アフリカ）
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BRAIN MONITORING DEVICES INDUSTRY
2.1 Summary about Brain Monitoring Devices Industry
2.2 Brain Monitoring Devices Market Trends
2.2.1 Brain Monitoring Devices Production & Consumption Trends
2.2.2 Brain Monitoring Devices Demand Structure Trends
2.3 Brain Monitoring Devices Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Electroencephalogram (EEG)
4.2.2 Computed Tomography (CT)
4.2.3 Magnetic Resonance Imaging (MRI)
4.2.4 Magnetoencephalogram (MEG)
4.2.5 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Neurological Centres
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Electroencephalogram (EEG)
5.2.2 Computed Tomography (CT)
5.2.3 Magnetic Resonance Imaging (MRI)
5.2.4 Magnetoencephalogram (MEG)
5.2.5 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Neurological Centres
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Electroencephalogram (EEG)
6.2.2 Computed Tomography (CT)
6.2.3 Magnetic Resonance Imaging (MRI)
6.2.4 Magnetoencephalogram (MEG)
6.2.5 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Neurological Centres
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Electroencephalogram (EEG)
7.2.2 Computed Tomography (CT)
7.2.3 Magnetic Resonance Imaging (MRI)
7.2.4 Magnetoencephalogram (MEG)
7.2.5 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Neurological Centres
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Electroencephalogram (EEG)
8.2.2 Computed Tomography (CT)
8.2.3 Magnetic Resonance Imaging (MRI)
8.2.4 Magnetoencephalogram (MEG)
8.2.5 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Neurological Centres
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Electroencephalogram (EEG)
9.2.2 Computed Tomography (CT)
9.2.3 Magnetic Resonance Imaging (MRI)
9.2.4 Magnetoencephalogram (MEG)
9.2.5 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Neurological Centres
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Medtronic
10.1.2 Johnson & Johnson
10.1.3 C.R. Bard
10.1.4 GE Healthcare
10.1.5 Siemens Healthcare
10.1.6 Philips Healthcare
10.1.7 Nihon Kohden
10.1.8 Compumedics
10.1.9 Toshiba
10.1.10 Medtronic (Covidien)
10.1.11 Natus Medical Incorporated
10.1.12 Advanced Brain Monitoring
10.1.13 Integra LifeSciences
10.1.14 CAS Medical Systems
10.2 Brain Monitoring Devices Sales Date of Major Players (2017-2020e)
10.2.1 Medtronic
10.2.2 Johnson & Johnson
10.2.3 C.R. Bard
10.2.4 GE Healthcare
10.2.5 Siemens Healthcare
10.2.6 Philips Healthcare
10.2.7 Nihon Kohden
10.2.8 Compumedics
10.2.9 Toshiba
10.2.10 Medtronic (Covidien)
10.2.11 Natus Medical Incorporated
10.2.12 Advanced Brain Monitoring
10.2.13 Integra LifeSciences
10.2.14 CAS Medical Systems
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
